CCL5 and type 2 diabetes mellitus: Moreover, T2DM individuals who were being treated with metformin had significantly reduced IL-8, IL-6, MCP-1, and RANTES in the presence of Mtb (Figure 3A) and reduced TNF-α and IL-6 in response to LPS (Figure 3B).